A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Qian Niu, MD
Ascentage Pharma
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pindara Private Hospital
Benowa, Queensland, Australia
Hanlon Sia, MDRecruiting - Sunshine Coast University Hospital
Birtinya, Queensland, Australia
Joshua Richmond, MDRecruiting - the Northern Hospital
Epping, Victoria, Australia
Chong C Chua, MDRecruiting - Royal Perth Hospital
Perth, Western Aus, Australia
Michael Leahy, MDRecruiting
- Ucla Medical Cetner Division of Hematology
Los Angeles, California, United States
Caspian Oliai, MDRecruiting - Novant Health
Charlotte, North Carolina, United States
Patricia Kropf, MDRecruiting - Novant Health
Winston-Salem, North Carolina, United States
James Dugan, MDRecruiting - Mdacc
Houston, Texas, United States
Tapan Kadia, MDRecruiting - Swedish Medical Center
Seattle, Washington, United States
Daniel Egan, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2021
- Primary completion
- 30 Jul 2024
- Completion
- 30 Oct 2024
- Last update posted
- 25 Oct 2023
- Registered enrollment
- 24
- Registry id
- NCT04964518
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.